Blood pressure-lowering effects of different dosage forms of orally administered valsartan on spontaneously hypertensive rats
碩士 === 嘉南藥理大學 === 藥學系 === 105 === Hypertension is a risk factor for cardiovascular disease in Taiwan, the first line of its clinical treatment, valsartan, which is an angiotensin II receptor blocker and not easily soluble in water. Previous studies have found several methods to improve valsartan...
Main Authors: | Hsu, SHIH-EN, 徐士恩 |
---|---|
Other Authors: | LIN, CHIAN-YUH |
Format: | Others |
Language: | zh-TW |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/y29sh8 |
Similar Items
-
Accuracy of Dose Administered to Children Using Off-Labelled or Unlicensed Oral Dosage Forms
by: Guillaume Binson, et al.
Published: (2021-07-01) -
EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
by: Zh. D. Kobalava, et al.
Published: (2017-07-01) -
An Insight Into Intestinal Microbiota of Spontaneously Hypertensive Rats After Valsartan Administration
by: Ying-Zi Qi, et al.
Published: (2021-04-01) -
Camellia oil lowering blood pressure in spontaneously hypertension rats
by: Lina Guo, et al.
Published: (2020-07-01) -
Tandospirone enhances the anti-myocardial fibrosis effect of valsartan in spontaneously hypertensive rats
by: Xuefei Huang, et al.
Published: (2020-06-01)